Free Trial

Stifel Nicolaus Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock

Hinge Health logo with Medical background

Key Points

  • Stifel Nicolaus has raised its price target for Hinge Health (NYSE:HNGE) from $48.00 to $55.00, indicating a potential upside of 21.68% from the stock's previous close.
  • Other analysts, including Canaccord Genuity Group and Royal Bank of Canada, have also issued positive ratings with price targets ranging from $45.00 to $58.00.
  • Hinge Health shares are currently trading at $45.20, showing a small increase of 0.6% during midday trading.
  • Looking to export and analyze Hinge Health data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Hinge Health (NYSE:HNGE - Free Report) had its price target increased by Stifel Nicolaus from $48.00 to $55.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other brokerages also recently weighed in on HNGE. William Blair assumed coverage on Hinge Health in a report on Monday, June 16th. They issued an "outperform" rating on the stock. JMP Securities assumed coverage on Hinge Health in a report on Monday, July 14th. They issued a "market outperform" rating and a $58.00 price target on the stock. Wall Street Zen upgraded Hinge Health to a "hold" rating in a report on Monday, June 2nd. Citigroup started coverage on Hinge Health in a research report on Monday, July 14th. They issued an "outperform" rating for the company. Finally, Truist Financial started coverage on Hinge Health in a research report on Monday, June 16th. They issued a "buy" rating and a $48.00 price objective for the company. One investment analyst has rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $49.86.

Check Out Our Latest Analysis on HNGE

Hinge Health Trading Down 2.7%

Hinge Health stock traded down $1.31 during midday trading on Friday, reaching $46.91. 596,625 shares of the stock traded hands, compared to its average volume of 868,940. Hinge Health has a 12 month low of $33.42 and a 12 month high of $52.16. The business's fifty day moving average price is $43.30.

Institutional Investors Weigh In On Hinge Health

Large investors have recently made changes to their positions in the company. Emerald Advisers LLC acquired a new position in Hinge Health in the 2nd quarter worth approximately $108,000. FNY Investment Advisers LLC acquired a new stake in shares of Hinge Health during the 2nd quarter valued at $310,000. Strategic Blueprint LLC acquired a new stake in shares of Hinge Health during the 2nd quarter valued at $346,000. Finally, CHURCHILL MANAGEMENT Corp acquired a new stake in shares of Hinge Health during the 2nd quarter valued at $828,000.

About Hinge Health

(Get Free Report)

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

Further Reading

Analyst Recommendations for Hinge Health (NYSE:HNGE)

Should You Invest $1,000 in Hinge Health Right Now?

Before you consider Hinge Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.

While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines